Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Combine: The Complete Guide for Women, Families, and Survivors
If you are a woman in Combine who is experiencing unexpected pain, redness, or the failure of a breast reconstruction or augmentation, you may feel as though your body has betrayed you. For many women across Dallas County, the journey toward healing after a mastectomy or the choice to undergo a cosmetic procedure is meant to be a path toward wholeness. However, when defective medical devices like surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffolds are used, that path often turns into a cycle of revision surgeries, systemic illness, or even a diagnosis of rare cancers like BIA-ALCL.
At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we recognize the specific challenges faced by patients in Combine. Whether you had your surgery at a major medical center in nearby Dallas or a specialist practice in Plano, the reality is that many of the devices implanted in women today were never fully vetted by the FDA for use in breast tissue. We are here to provide the substantive legal and scientific education you need to regain your agency. Managing Partner Ralph Manginello, with twenty-seven years of continuous legal practice, and Associate Attorney Lupe Peña, who provides full consultations in fluent Spanish, are dedicated to holding manufacturers accountable for the “predicate creep” and regulatory shortcuts that have put women in Combine at risk.
You are not alone in this search for answers. This guide is built to be the definitive resource for Combine residents, covering everything from the 510(k) clearance pathway to the emerging pathology of Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). When you are ready to speak, our team is available at 1-888-ATTY-911 for a confidential, no-obligation consultation.
The Local Reality for Patients in Combine
While Combine offers a peaceful, rural-suburban lifestyle on the edge of the Dallas-Fort Worth Metroplex, most residents travel into the heart of Dallas or the northern suburbs for specialized surgical care. Whether you sought treatment at an NCI-designated comprehensive cancer center or a high-volume aesthetic practice, the devices used in your body—such as GalaFLEX, Phasix, or AlloDerm—are subject to federal and Texas state laws.
Because Combine sits on the border of Dallas and Kaufman counties, the jurisdictional questions of your case are complex. We understand the Dallas County court system and have extensive experience in the United States District Court for the Southern District of Texas, as well as the Northern District which oversees federal cases arising from Combine. We focus on the “learned intermediary” doctrine and how manufacturer marketing in North Texas may have mislead local surgeons about the safety of off-label mesh applications.
Understanding the Devices: Mesh, ADM, and Scaffolds
Many women in Combine are surprised to learn that the “internal bra” or “scaffold” mentioned by their surgeon is actually a form of surgical mesh. These products generally fall into three categories, each carries its own set of risks and regulatory histories.
Acellular Dermal Matrix (ADM)
ADM is a biologic material derived from human or animal skin. Manufacturers like Allergan (AbbVie), Becton Dickinson (BD), and MTF Biologics wash these tissues to remove cells while leaving a structural collagen matrix. In Combine, these are frequently used in “staged” breast reconstructions to help support a tissue expander or implant. Brands like AlloDerm, Strattice, and FlexHD are common. However, the FDA’s March 31, 2021 communication specifically warned that FlexHD and AlloMax showed significantly higher rates of reoperation and infection.
Bioabsorbable Scaffolds
These are synthetic materials designed to disappear over time. The most prominent material is poly-4-hydroxybutyrate (P4HB), used in GalaFLEX and Phasix. Manufacturers claim these scaffolds provide support for 12 to 24 months before dissolving. However, reports to the FDA’s MAUDE database suggest that for some women, these scaffolds do not resorb as advertised, leading to chronic inflammation, palpable edges, and “red breast syndrome.”
Synthetic Mesh
Traditional polypropylene mesh, commonly used in hernia repairs, is occasionally used off-label in breast surgery. These permanent synthetics are often poorly tolerated by sensitive breast tissue, leading to erosion and chronic infection.
The 510(k) Regulatory Failure: Predicate Creep and Combine Patients
The most critical fact for any Combine resident to understand is that the FDA has never determined that surgical mesh is safe or effective for use in breast surgery. This was stated verbatim in the FDA’s November 9, 2023 letter to healthcare providers.
The reason these devices are in operating rooms at all is the 510(k) clearance pathway (21 USC §360c). Unlike the Premarket Approval (PMA) pathway, which requires rigorous human clinical trials, the 510(k) pathway only requires a manufacturer to show that a device is “substantially equivalent” to a “predicate device” already on the market.
In a process known as “predicate creep,” a device like GalaFLEX was cleared because it was compared to a surgical suture. This comparison is a regulatory fiction. A suture is used for wound closure; a scaffold is used for whole-organ reinforcement. Under the landmark Supreme Court case Medtronic v. Lohr, 518 U.S. 470 (1996), 510(k) clearance does not preempt state-law injury claims. This means that if you were injured in Combine, the manufacturer cannot hide behind a “federal approval” that never actually happened.
Complications and Pathologies: What You Need to Know
If you are experiencing complications in Combine, it is vital to secure your medical records and identify the specific brand of mesh or ADM used. We frequently assist clients in tracking down “implant stickers” and operative reports to confirm the manufacturer.
BIA-ALCL: The Textured Implant Cancer
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a distinct T-cell lymphoma, recognized by the World Health Organization since 2016. It is not breast cancer; it is a cancer of the immune system found in the fluid or scar tissue around the implant.
- Pathology: CD30 positive, ALK negative.
- Classic Presentation: Delayed seroma (fluid buildup) occurring 7 to 10 years after surgery.
- Direct Cause: The textured surface of the implant, particularly the Allergan BIOCELL line, which is currently the subject of MDL 2921 in the District of New Jersey.
BIA-SCC: Emerging Squamous Cell Carcinoma
A more recent concern recognized by the FDA in September 2022 is Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). This epithelial tumor is found in the implant capsule and has been reported in both smooth and textured implants. The latency can be decades, making long-term monitoring essential for Combine residents who had surgery years ago.
Red Breast Syndrome (RBS)
Specifically associated with ADM products like Strattice or FlexHD, Red Breast Syndrome is a non-infectious, sterile inflammation. Research suggests it is caused by endotoxins (lipopolysaccharides) retained on the biologic matrix even after sterilization. For a woman in Combine, this often looks like a post-operative infection, but it does not respond to antibiotics because the cause is a chemical reaction to the device itself.
Sepsis and Systemic Infection
When a device like FlexHD or AlloMax becomes colonized with bacteria, a biofilm forms that is nearly impossible to treat without removing the device. This can lead to life-threatening sepsis. We are particularly concerned about reports involving Becton Dickinson (BD) products where whistleblower Dr. Hooman Noorchashm has alleged that critical safety data was withheld from the FDA.
The Legal Landscape in Texas and Combine
When we represent a client from Combine, we look at several legal theories to ensure the maximum possible recovery for the physical and emotional trauma you have endured.
Strict Product Liability
Under Texas law, a manufacturer is strictly liable for design defects, manufacturing defects, and failures to warn. If the GalaFLEX or Phasix used in your procedure was marketed to your surgeon for an unapproved breast application without disclosing the lack of safety data, the manufacturer has failed in its duty to warn.
Off-Label Promotion Liability
While surgeons have the right to use devices “off-label,” manufacturers are generally prohibited from promoting unapproved uses. If a sales representative in Dallas or Combine encouraged your surgeon to use a mesh product for an “internal bra” technique, they may have crossed a legal line that allows us to hold the corporation directly accountable.
Texas Damages Framework
In Combine and throughout Texas, we must navigate the Texas Civil Practice and Remedies Code.
- Statute of Limitations: Generally two years from the date of injury or the date the injury was discovered.
- Discovery Rule: Because many mesh injuries take years to manifest, the “discovery rule” is vital. Your clock might not have started until you saw the 2023 FDA warning or until a revision surgeon in Dallas explained that the mesh was the cause of your pain.
- Damage Caps: Texas law (Chapter 74) imposes a $250,000 cap on non-economic damages (pain and suffering) for medical malpractice, but this cap generally does not apply to “pure” product liability claims against the manufacturer.
Why The Manginello Law Firm is the Choice for Combine
When you are facing a multi-billion-dollar corporation like AbbVie, Johnson & Johnson, or Becton Dickinson, you need a firm that is currently litigating high-stakes, multi-defendant cases.
Our firm is lead counsel in Bermudez v. Pi Kappa Phi, a high-profile case involving thirteen defendants and institutional liability. We apply that same aggressive, investigative approach to defective device litigation. Ralph Manginello’s twenty-seven years of continuous practice and his membership in the Pro Bono College of the State Bar of Texas reflect a career dedicated to high-level advocacy and service.
Furthermore, we recognize that Combine’s diverse population includes many Spanish-speaking families who may feel silenced by the medical and legal systems. Lupe Peña conducts full consultations in fluent Spanish, ensuring that nothing is lost in translation during your case. Whether you are more comfortable speaking English or Spanish, our firm provides a direct line to your attorney. Hablamos español y estamos listos para luchar por usted.
The Defense Playbook: How We Counter Their Arguments
Manufacturers and their insurance carriers in Dallas County follow a predictable script. We are prepared to counter every point.
- “The Surgeon is to Blame”: They will invoke the “learned intermediary” doctrine, claiming they warned the doctor, and the rest is the doctor’s fault. We counter this by showing that the manufacturer’s off-label marketing was specifically designed to mislead your surgeon.
- “The FDA Cleared It”: They will point to the 510(k) clearance. We use Medtronic v. Lohr and the FDA’s own 2023 letter to prove that 510(k) is not a safety approval.
- “It’s a Rare Side Effect”: They will cite low incidence rates. We use the peer-reviewed meta-analyses showing that ADM increases infection risk by a factor of 2.7.
Frequently Asked Questions for Residents of Combine
Is the mesh used in my breast reconstruction FDA-approved?
No. The FDA confirmed in November 2023 that “no surgical mesh products have been cleared or approved by the FDA for use in breast surgery.” They have only been cleared for general tissue reinforcement or hernia repair.
How long do I have to file a lawsuit in Combine?
Under the Texas statute of limitations, you typically have two years. However, the discovery rule may extend this period if you only recently learned that the mesh was the cause of your complications. It is critical to call 1-888-ATTY-911 to discuss your specific timeline.
Can I sue if my GalaFLEX scaffold hasn’t dissolved yet?
Yes. If the product was marketed as being bioabsorbable within 18 months but is still causing pain or inflammation years later, this may constitute a design defect or a failure to warn.
What if my original surgeon is in Dallas, but I live in Combine?
The location of your surgery determines where the case could be filed, but as a Combine resident, you have the right to seek counsel that can represent you in Dallas County or federal courts. Our firm serves the entire North Texas region.
Do I have to pay anything upfront?
No. At Attorney911, we work on a contingency fee basis. This means we advance all costs of litigation, including hiring expert pathologists and regulatory specialists. We only get paid if we recover compensation for you.
Evidence Preservation for Your Combine Case
If you are scheduled for a revision or removal surgery in the Dallas area, time is of the essence.
- Request Your Devices: Ask your surgeon to preserve the explanted mesh or ADM. It is your property.
- Secure Pathology: Ensure that the pathology lab preserves all slides and tissue blocks. These are the primary evidence of CD30+ BIA-ALCL or sterile inflammation.
- Photographic Record: Document the appearance of the breast (redness, swelling, asymmetry) before the revision surgery.
Immediate Next Steps for Combine Survivors
The path from injury to justice begins with a single conversation. Whether you are dealing with a recent BIA-ALCL diagnosis, the loss of your reconstruction due to a FlexHD infection, or chronic pain from a GalaFLEX scaffold, our firm is ready to stand with you.
Ralph Manginello and Lupe Peña have built a reputation for handling complex, institutional-liability cases that other firms find too daunting. With hundreds of five-star reviews on Birdeye and an “Excellent” rating on Avvo, we combine the resources of a premier litigation firm with the personalized attention you deserve in Combine.
Do not allow a manufacturer’s regulatory shortcuts to be the final word on your health. Call Attorney911 at 1-888-288-9911 today. We are here to listen, to investigate, and to fight for the compensation you need for medical bills, lost wages, and the pain you have endured.
The Manginello Law Firm, PLLC (Attorney911)
Principal Office: 1177 West Loop South, Suite 1600, Houston, TX 77027
Serving Combine, Dallas County, and all of Texas.
1-888-ATTY-911
Your consultation is free. Our commitment is absolute. No fee unless we recover for you.
